View Older Stories View More Recent Stories

Aug 15, 2022 05:13PM Form SC 13G/A KalVista Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 15, 2022 05:11PM Form SC 13G/A TScan Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 15, 2022 05:07PM Form SC 13G/A Cyteir Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 15, 2022 05:04PM Form SC 13G/A Akouos, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 15, 2022 05:00PM Form SC 13G/A Edgewise Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 12, 2022 04:34PM Form SC 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 11, 2022 04:00PM Celcuity Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Aug 10, 2022 07:00AM GentiBio Announces Collaboration with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for Inflammatory Bowel Diseases
Aug 4, 2022 07:00AM Concert Pharmaceuticals Reports Second Quarter 2022 Financial Results
Jul 26, 2022 10:00AM Scribe Therapeutics Announces Expansion of San Francisco Bay Area Headquarters, 3 Key Senior Hires
Jul 26, 2022 07:00AM Carmot Therapeutics closes $160 million Series D financing to advance clinical pipeline of novel incretin receptor modulators
Jul 25, 2022 08:03AM NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation (FLAC) Announce Merger Agreement
Jul 25, 2022 08:00AM NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiom
Jul 20, 2022 08:00AM Medical Microinstruments Secures $75M to Advance Robotic Microsurgery
Jul 15, 2022 10:00AM Scribe Therapeutics to Participate in SVB Securities Biopharma Private Company Connect
Jul 13, 2022 05:45AM Hemab Therapeutics Presents New Data on HMB-001 for the Treatment of Glanzmann Thrombasthenia and Other Bleeding Disorders at 2022 ISTH Congress
Jul 12, 2022 08:15AM NAPIGEN Completes $7.85 Million Funding Round to Advance Its Mitochondrial and Chloroplast Gene Editing Technology
Jul 6, 2022 05:25PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 5, 2022 08:00AM 89bio Announces Closing of its Upsized $94.5 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
Jun 28, 2022 09:05AM Cerebral Therapeutics, Inc. Secures $40 Million Series C Financing
Jun 28, 2022 08:00AM Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard® in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (S
Jun 28, 2022 07:30AM DTx Pharma Appoints Peter Condon as Chief Business Officer
Jun 23, 2022 04:50PM Form SC 13D/A PepGen Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 22, 2022 04:32PM Form SC 13G Instil Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 21, 2022 04:36PM Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 15, 2022 08:00AM Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer
Jun 14, 2022 09:00AM WAVE Life Sciences (WVE) Announces Pricing of $70.0 Million Underwritten Offering
Jun 14, 2022 09:00AM Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering
Jun 14, 2022 09:00AM Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering
Jun 9, 2022 02:55AM DBV Technologies Announces Private Placement Financing of $194 Million
Jun 9, 2022 02:55AM DBV Technologies Announces Private Placement Financing of $194 Million
Jun 8, 2022 08:00AM Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension
Jun 6, 2022 04:01PM Concert Pharmaceuticals Raises Gross Proceeds of $66.4 Million Through Public Offering and Exercise of Warrants
Jun 3, 2022 05:12PM Form SC 13D/A Kala Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 1, 2022 06:00AM Form SC 13D/A Kala Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 31, 2022 07:30AM DTx Pharma Appoints Michael Huang, MD as Chief Medical Officer
May 25, 2022 05:14PM Form SC 13D/A Kala Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 25, 2022 04:31PM Form SC 13G Celcuity Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 25, 2022 10:00AM Adela Initiates Key Study for Cancer Early Detection Program
May 23, 2022 10:00AM Adela Announces Executive and Board of Directors Appointments and Formation of Scientific Advisory Board
May 20, 2022 04:31PM Form SC 13D PepGen Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 19, 2022 06:30AM Be Bio and Resilience Announce Strategic Collaboration to Manufacture Engineered B Cells, a New Class of Cellular Medicines
May 16, 2022 06:18PM Form SC 13G/A Bolt Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 16, 2022 05:51PM Form SC 13G/A Olema Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 16, 2022 05:04PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
May 16, 2022 05:03PM Form SC 13G/A Phathom Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 16, 2022 04:52PM Form SC 13G/A ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 16, 2022 04:00PM Celcuity Inc. Reports First Quarter 2022 Financial Results and Business Updates
May 16, 2022 08:00AM Avilar Therapeutics Announces Formation of Scientific Advisory Board With Leading Experts in Protein Degradation, Chemistry, Genetics, and Drug Discovery
May 16, 2022 07:03AM Celcuity (CELC) Announces $100M Private Placement
View More Recent Stories View Older Stories